About Windward Bio
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Round
Global Headquarters
Basel, Switzerland
Team Size
11–50 employees
Tracked Since
Nov 6, 2026
Web & Domain Identity
Official Website
windwardbio.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised undisclosed · Round
fundraisingfox.com
- Capital Raise
Raised $200,000,000 · Series-A
Backed by Blue Owl Capital
Investors & Backers
Blue Owl Capital
Lead
Harbour Biomed
Janus Henderson Investors
Novo Holdings
Omega Funds
OrbiMed
Pivotal bioVenture Partners
Qiming Venture Partners
Quan Capital
RA Capital Management
RTW Investments
Sanofi Ventures
SR One
Funding History
Round equity
· May 5, 2026
undisclosed fundraisingfox.com
Series-A equity
· Jan 10, 2025
Round backers: Blue Owl Capital
$200,000,000 globenewswire.com
Founders & Leadership
Claudia D’Augusta
Chief Financial Officer
Work email & phone locked
Unlock →
Jeffrey Stavenhagen
Chief Scientific Officer
Work email & phone locked
Unlock →
Kevin Harris
Chief Operating Officer
Work email & phone locked
Unlock →
Luca Santarelli
Founder
Work email & phone locked
Unlock →
Omar Khwaja
Chief Medical Officer
Work email & phone locked
Unlock →
Scott Applebaum
Chief Legal & Corporate Development Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026